Metagenomi

Emeryville, United States

Metagenomi uses metagenomics and machine learning to discover novel genome editing systems for therapeutics development.

$100.0M raised

Jan 2023

Series B

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Metagenomi raised?

Metagenomi has raised $100.0M in total funding. The most recent round was Series B. The last funding was announced in January 2023.

Who are Metagenomi's investors?

Metagenomi's investors include RA Capital Management, HOF Capital, Catalio Capital Management, Moderna, Sozo Ventures.

Where is Metagenomi headquartered?

Metagenomi is headquartered in Emeryville, United States.

What does Metagenomi do?

Metagenomi uses metagenomics and machine learning to discover novel genome editing systems for therapeutics development.

What stage is Metagenomi at?

Metagenomi is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 5, 2023.

MLA

"Metagenomi — Funding & Investors." VCBacked, January 5, 2023, https://www.vcbacked.co/company/metagenomi. Accessed July 2, 2026.

APA

VCBacked. (2023). Metagenomi — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/metagenomi

Wikipedia (cite web)

{{cite web |title=Metagenomi — Funding & Investors |url=https://www.vcbacked.co/company/metagenomi |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 5, 2023.